Request for Information for the Development of the Fiscal Year 2019 Trans-NIH Plan for HIV-Related Research, 15526 [2017-06183]

Download as PDF 15526 Federal Register / Vol. 82, No. 59 / Wednesday, March 29, 2017 / Notices Date: April 21, 2017. Time: 9:30 a.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, Contact Person: Xiang-Ning Li, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5112, MSC 7854, Bethesda, MD 20892, 301–435– 1744, lixiang@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: March 23, 2017. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–06147 Filed 3–28–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Request for Information for the Development of the Fiscal Year 2019 Trans-NIH Plan for HIV-Related Research Through this Request for Information (RFI), the Office of AIDS Research (OAR) in the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), National Institutes of Health (NIH), invites feedback from investigators in academia, industry, health care professionals, patient advocates and health advocacy organizations, scientific or professional organizations, federal agencies, community, and other interested constituents on the development of the fiscal year (FY) 2019 Trans-NIH Plan for HIV-Related Research (FY 2019 AIDS Research Plan). This plan is designed to identify and articulate future directions to maximize the NIH’s investments in HIV/AIDS research. DATES: The OAR’s Request for Information is open for public comment for a period of 45 days. Comments must be received by May 15, 2017 to ensure consideration. After the public comment period has closed, the comments received by the OAR will be considered in a timely manner for the development of the FY2019 AIDS Research Plan. ADDRESSES: Submissions may be electronically sent to http:// grants.nih.gov/grants/rfi/rfi.cfm?ID=63 or, if needed, by mail to Paul Gaist, Ph.D., M.P.H. Office of AIDS Research, mstockstill on DSK3G9T082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:54 Mar 28, 2017 Jkt 241001 National Institutes of Health, Room 2E40, 5601 Fishers Lane, Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: Questions about this request for information should be directed to Paul Gaist, Ph.D., M.P.H. Office of AIDS Research, National Institutes of Health Email: ODOARRFI19@nih.gov or if needed, by mail to Room 2E40, 5601 Fishers Lane, Rockville, Maryland 20852. This RFI is for planning purposes only and should not be construed as a solicitation for applications or proposals, or as an obligation in any way on the part of the United States federal government. The federal government will not pay for the preparation of any information submitted or for the government’s use. Additionally, the government cannot guarantee the confidentiality of the information provided. To access and respond to the RFI, go to the following Web address: http://grants. nih.gov/grants/rfi/rfi.cfm?ID=63. OAR oversees and coordinates the conduct and support of all HIV/AIDS research activities across the NIH Institutes and Centers (ICs). The NIHsponsored HIV/AIDS research program includes both extramural and intramural research, buildings and facilities, research training, program evaluation, and supports a comprehensive portfolio of research representing a broad range of basic, clinical, behavioral, social science, and translational research on HIV/AIDS and its associated coinfections and comorbidities. OAR plans and coordinates research through the development of an annual Trans-NIH Plan for HIV-Related Research that articulates the overarching HIV/AIDS research priorities and serves as the framework for developing the trans-NIH HIV/AIDS research budget. This Plan provides information about the NIH’s HIV/AIDS research priorities to the scientific community, Congress, community stakeholders, HIV-affected communities, and the broad public at large. The fiscal year 2018 Trans-NIH Plan for HIV-Related Research was recently distributed on the OAR Web site: (https://www.oar.nih.gov/strategic_ plan/plan_18.asp). New overarching priorities for HIV/ AIDS research were defined in the NIH Director’s Statement of August 12, 2015 (https://grants.nih.gov/grants/guide/ notice-files/NOT-OD-15-137.html). High Priority topics of research for support include: (1) Reducing the incidence of HIV/ AIDS; (2) Developing the next generation of HIV therapies; (3) Identifying strategies towards a cure; (4) Improving the prevention and treatment of HIV-associated comorbidities, coinfections, and complications; and (5) Cross-cutting basic research, behavioral and social science research, health disparities, and training. Dated: March 23, 2017. Lawrence A. Tabak, Deputy Director, National Institutes of Health. SUPPLEMENTARY INFORMATION: PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 [FR Doc. 2017–06183 Filed 3–28–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the National Center for Advancing Translational Sciences. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Cures Acceleration Network Review Board. Date: May 4, 2017. Time: 8:30 a.m. to 2:30 p.m. Agenda: Report from the Institute Director. Place: National Institutes of Health, Building 31, Conference Room 6, 31 Center Drive, Bethesda, MD 20892. Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive Secretary, National Center for Advancing Translational Sciences, 1 Democracy Plaza, Room 1072, Bethesda, MD 20892, 301–435–0809, anna.ramseyewing@ nih.gov. E:\FR\FM\29MRN1.SGM 29MRN1

Agencies

[Federal Register Volume 82, Number 59 (Wednesday, March 29, 2017)]
[Notices]
[Page 15526]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06183]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Request for Information for the Development of the Fiscal Year 
2019 Trans-NIH Plan for HIV-Related Research

SUMMARY: Through this Request for Information (RFI), the Office of AIDS 
Research (OAR) in the Division of Program Coordination, Planning, and 
Strategic Initiatives (DPCPSI), National Institutes of Health (NIH), 
invites feedback from investigators in academia, industry, health care 
professionals, patient advocates and health advocacy organizations, 
scientific or professional organizations, federal agencies, community, 
and other interested constituents on the development of the fiscal year 
(FY) 2019 Trans-NIH Plan for HIV-Related Research (FY 2019 AIDS 
Research Plan). This plan is designed to identify and articulate future 
directions to maximize the NIH's investments in HIV/AIDS research.

DATES: The OAR's Request for Information is open for public comment for 
a period of 45 days. Comments must be received by May 15, 2017 to 
ensure consideration. After the public comment period has closed, the 
comments received by the OAR will be considered in a timely manner for 
the development of the FY2019 AIDS Research Plan.

ADDRESSES: Submissions may be electronically sent to http://grants.nih.gov/grants/rfi/rfi.cfm?ID=63 or, if needed, by mail to Paul 
Gaist, Ph.D., M.P.H. Office of AIDS Research, National Institutes of 
Health, Room 2E40, 5601 Fishers Lane, Rockville, Maryland 20852.

FOR FURTHER INFORMATION CONTACT: Questions about this request for 
information should be directed to Paul Gaist, Ph.D., M.P.H. Office of 
AIDS Research, National Institutes of Health Email: ODOARRFI19@nih.gov 
or if needed, by mail to Room 2E40, 5601 Fishers Lane, Rockville, 
Maryland 20852.

SUPPLEMENTARY INFORMATION: To access and respond to the RFI, go to the 
following Web address: http://grants.nih.gov/grants/rfi/rfi.cfm?ID=63.
    OAR oversees and coordinates the conduct and support of all HIV/
AIDS research activities across the NIH Institutes and Centers (ICs). 
The NIH-sponsored HIV/AIDS research program includes both extramural 
and intramural research, buildings and facilities, research training, 
program evaluation, and supports a comprehensive portfolio of research 
representing a broad range of basic, clinical, behavioral, social 
science, and translational research on HIV/AIDS and its associated 
coinfections and comorbidities.
    OAR plans and coordinates research through the development of an 
annual Trans-NIH Plan for HIV-Related Research that articulates the 
overarching HIV/AIDS research priorities and serves as the framework 
for developing the trans-NIH HIV/AIDS research budget. This Plan 
provides information about the NIH's HIV/AIDS research priorities to 
the scientific community, Congress, community stakeholders, HIV-
affected communities, and the broad public at large. The fiscal year 
2018 Trans-NIH Plan for HIV-Related Research was recently distributed 
on the OAR Web site: (https://www.oar.nih.gov/strategic_plan/plan_18.asp).
    New overarching priorities for HIV/AIDS research were defined in 
the NIH Director's Statement of August 12, 2015 (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html).
    High Priority topics of research for support include:
    (1) Reducing the incidence of HIV/AIDS;
    (2) Developing the next generation of HIV therapies;
    (3) Identifying strategies towards a cure;
    (4) Improving the prevention and treatment of HIV-associated 
comorbidities, coinfections, and complications; and
    (5) Cross-cutting basic research, behavioral and social science 
research, health disparities, and training.
    This RFI is for planning purposes only and should not be construed 
as a solicitation for applications or proposals, or as an obligation in 
any way on the part of the United States federal government. The 
federal government will not pay for the preparation of any information 
submitted or for the government's use. Additionally, the government 
cannot guarantee the confidentiality of the information provided.

    Dated: March 23, 2017.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2017-06183 Filed 3-28-17; 8:45 am]
 BILLING CODE 4140-01-P